Vietnam’s Proteomics Market Gains Momentum as Precision Medicine and Biotech Research Expand

Vietnam’s life sciences sector is entering a new phase of development as investment in biotechnology, pharmaceutical research and precision medicine increases demand for advanced protein analysis technologies.

While there is currently no independently published valuation for Vietnam’s overall Proteomics Market, analysis of the country’s wider life science tools, protein analysis and biotechnology markets indicates that the sector could be worth approximately US$90–120 million in 2025, potentially reaching US$175–230 million by 2030.

The figures should be regarded as an indicative market estimate rather than a published industry valuation. However, several directly related Vietnamese markets demonstrate the scale of the opportunity.

Vietnam’s Life Science Tools Market, which includes proteomics technologies and mass spectrometry, reached US$712.2 million in 2025 and is forecast to grow to US$1.41 billion by 2034, while the country’s Protein Purification and Isolation Market reached US$53.6 million in 2025 and is projected to reach US$102.2 million by 2034.

Proteomics is the large-scale study of proteins — their structures, functions, interactions and changes within cells and tissues. Because proteins are directly involved in most biological processes, proteomics is becoming increasingly important in understanding disease, discovering biomarkers and developing new medicines.

The sector encompasses technologies and services including:

• Mass spectrometry
• Protein separation and purification
• Protein microarrays
• Chromatography
• Electrophoresis
• Protein sequencing
• Protein detection and quantification
• Bioinformatics
• Biomarker discovery
• Single-cell proteomics

Precision medicine is one of the strongest drivers of growth. Researchers are increasingly combining proteomic information with genomics and other molecular data to understand why diseases develop differently between individuals and identify treatments targeted to specific biological characteristics.

This is particularly important in oncology, where proteomics can help identify cancer biomarkers, understand tumour biology, discover therapeutic targets and monitor responses to treatment. Similar applications are emerging across cardiovascular disease, neurological disorders, infectious diseases and immune-mediated conditions.

Vietnam already has a growing ecosystem supporting these technologies. The country has dedicated markets for protein sequencing, protein detection and quantification, protein purification and single-cell multiomics, with research providers highlighting pharmaceutical R&D, biotechnology investment and personalised medicine as important drivers of future demand.

Mass spectrometry is particularly important to the development of proteomics. Modern high-resolution mass spectrometers allow researchers to identify and quantify thousands of proteins within complex biological samples, making the technology central to biomarker discovery, drug development and translational research.

Proteomics is also becoming increasingly interconnected with genomics. Next-generation sequencing can identify genetic changes associated with disease, while proteomics helps researchers understand how those genetic changes ultimately affect proteins and biological pathways. Combining the two provides a more complete picture of disease biology and is helping accelerate the development of precision medicine.

Artificial intelligence is adding another dimension. Proteomics experiments can generate enormous datasets, and AI and machine-learning platforms are increasingly being used to identify patterns, discover biomarkers and interpret complex protein interactions. This is helping researchers move from simply measuring proteins towards predicting disease behaviour and potential therapeutic responses.

The international outlook demonstrates the scale of the opportunity. The global Proteomics Market reached US$47.2 billion in 2025 and is forecast to reach US$148.1 billion by 2034, representing annual growth of 13.14%. Growth is being driven by advances in mass spectrometry, increasing pharmaceutical and biotechnology R&D, rising chronic disease prevalence and the shift towards personalised medicine.

Vietnam could potentially grow faster than the established global market as its research infrastructure develops. The country’s wider Life Science Tools Market is forecast to almost double from US$712.2 million in 2025 to US$1.41 billion by 2034, demonstrating increasing investment in the laboratory technologies required to support genomics, proteomics, cell biology and pharmaceutical research.

The opportunity extends beyond research laboratories. Proteomics technologies have applications across pharmaceutical development, clinical diagnostics, biotechnology, academic research, contract research, biomarker discovery and drug development, creating opportunities throughout Vietnam’s expanding life sciences ecosystem.

For manufacturers of mass spectrometers, chromatography systems, protein analysis platforms, laboratory automation, reagents and consumables, as well as biotechnology companies, CROs and bioinformatics providers, Vietnam represents a developing market with considerable long-term potential.

As Vietnam continues to expand its pharmaceutical, biotechnology and precision medicine capabilities, proteomics is expected to become an increasingly important part of the country’s life sciences infrastructure — helping connect fundamental biological research with the next generation of diagnostics and personalised therapies.

READ THE FULL INSIGHTS REPORT